Literature DB >> 16585051

Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.

Dirk Fischer1, Muriel Herasse, Marc Bitoun, Héctor M Barragán-Campos, Jacques Chiras, Pascal Laforêt, Michel Fardeau, Bruno Eymard, Pascale Guicheney, Norma B Romero.   

Abstract

Centronuclear myopathy (CNM) is a slowly progressive congenital myopathy characterized by abnormal centrally located nuclei in a large number of muscle fibres. Recently, different missense mutations affecting the middle domain of the dynamin 2 (DNM2) have been shown to cause autosomal dominant CNM. In order to better define the phenotype of DNM2-related CNM, we report here on the clinical and muscle imaging findings of 10 patients harbouring DNM2 mutations. DNM2-CNM is characterized by slowly progressive muscular weakness usually beginning in adolescence or early adulthood. In addition to bilateral ptosis, our data show that distal muscle weakness often exceeds proximal involvement. Furthermore, electrophysiological investigations frequently demonstrated signs of mild axonal peripheral nerve involvement, and electromyographical examination may show neuropathic changes in addition to the predominant myopathic changes. These features overlap with findings seen in the phenotype of DNM2-related autosomal dominant Charcot-Marie-Tooth disease type 2B. In all 10 DNM2-CNM patients, muscle computer tomography assessment showed a consistent pattern of muscular involvement and a characteristic temporal course with early and predominant distal muscle involvement, and later affection of the posterior thigh compartment and gluteus minimus muscles. The recognition of this specific imaging pattern of muscle involvement--distinct to the reported patterns in other congenital myopathies--may enable a better selection for direct genetic testing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585051     DOI: 10.1093/brain/awl071

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

1.  Clinical utility gene card for: Centronuclear and myotubular myopathies.

Authors:  Valérie Biancalana; Alan H Beggs; Soma Das; Heinz Jungbluth; Wolfram Kress; Ichizo Nishino; Kathryn North; Norma B Romero; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

2.  A Roma founder BIN1 mutation causes a novel phenotype of centronuclear myopathy with rigid spine.

Authors:  Macarena Cabrera-Serrano; Fabiola Mavillard; Valerie Biancalana; Eloy Rivas; Bharti Morar; Aurelio Hernández-Laín; Montse Olive; Nuria Muelas; Eduardo Khan; Alejandra Carvajal; Pablo Quiroga; Jordi Diaz-Manera; Mark Davis; Rainiero Ávila; Cristina Domínguez; Norma Beatriz Romero; Juan J Vílchez; David Comas; Nigel G Laing; Jocelyn Laporte; Luba Kalaydjieva; Carmen Paradas
Journal:  Neurology       Date:  2018-06-27       Impact factor: 9.910

3.  Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.

Authors:  F Hanisch; T Müller; A Dietz; M Bitoun; W Kress; J Weis; G Stoltenburg; S Zierz
Journal:  J Neurol       Date:  2011-01-09       Impact factor: 4.849

4.  Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.

Authors:  Johann Böhm; Valérie Biancalana; Elizabeth T Dechene; Marc Bitoun; Christopher R Pierson; Elise Schaefer; Hatice Karasoy; Melissa A Dempsey; Fabrice Klein; Nicolas Dondaine; Christine Kretz; Nicolas Haumesser; Claire Poirson; Anne Toussaint; Rebecca S Greenleaf; Melissa A Barger; Lane J Mahoney; Peter B Kang; Edmar Zanoteli; John Vissing; Nanna Witting; Andoni Echaniz-Laguna; Carina Wallgren-Pettersson; James Dowling; Luciano Merlini; Anders Oldfors; Lilian Bomme Ousager; Judith Melki; Amanda Krause; Christina Jern; Acary S B Oliveira; Florence Petit; Aurélia Jacquette; Annabelle Chaussenot; David Mowat; Bruno Leheup; Michele Cristofano; Juan José Poza Aldea; Fabrice Michel; Alain Furby; Jose E Barcena Llona; Rudy Van Coster; Enrico Bertini; Jon Andoni Urtizberea; Valérie Drouin-Garraud; Christophe Béroud; Bernard Prudhon; Melanie Bedford; Katherine Mathews; Lori A H Erby; Stephen A Smith; Jennifer Roggenbuck; Carol A Crowe; Allison Brennan Spitale; Sheila C Johal; Anthony A Amato; Laurie A Demmer; Jessica Jonas; Basil T Darras; Thomas D Bird; Mercy Laurino; Selman I Welt; Cynthia Trotter; Pascale Guicheney; Soma Das; Jean-Louis Mandel; Alan H Beggs; Jocelyn Laporte
Journal:  Hum Mutat       Date:  2012-04-04       Impact factor: 4.878

Review 5.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

6.  Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.

Authors:  Teerin Liewluck; Tracy L Lovell; Anna V Bite; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2010-12       Impact factor: 4.296

7.  Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation.

Authors:  Elena Gallardo; Kristl G Claeys; Eva Nelis; Antonio García; Ana Canga; Onofre Combarros; Vincent Timmerman; Peter De Jonghe; José Berciano
Journal:  J Neurol       Date:  2008-06-17       Impact factor: 4.849

8.  Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy.

Authors:  Young-Eun Park; Young-Chul Choi; Jong-Suk Bae; Chang-Hoon Lee; Hyang-Suk Kim; Jin-Hong Shin; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

9.  Autosomal dominant centronuclear myopathy with unique clinical presentations.

Authors:  Jee Young Lee; Ju Hong Min; Yoon Ho Hong; Jung Joon Sung; Sung Hye Park; Seong Ho Park; Kwang Woo Lee; Kyung Seok Park
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

10.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.